KR101477123B1 - 항체결합 펩타이드-페리틴 융합단백질 및 이의 용도 - Google Patents

항체결합 펩타이드-페리틴 융합단백질 및 이의 용도 Download PDF

Info

Publication number
KR101477123B1
KR101477123B1 KR1020120109748A KR20120109748A KR101477123B1 KR 101477123 B1 KR101477123 B1 KR 101477123B1 KR 1020120109748 A KR1020120109748 A KR 1020120109748A KR 20120109748 A KR20120109748 A KR 20120109748A KR 101477123 B1 KR101477123 B1 KR 101477123B1
Authority
KR
South Korea
Prior art keywords
antibody
ferritin
protein
binding peptide
binding
Prior art date
Application number
KR1020120109748A
Other languages
English (en)
Korean (ko)
Other versions
KR20130039672A (ko
Inventor
정상전
강세병
강효진
강영지
이영미
Original Assignee
한국생명공학연구원
국립대학법인 울산과학기술대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국생명공학연구원, 국립대학법인 울산과학기술대학교 산학협력단 filed Critical 한국생명공학연구원
Publication of KR20130039672A publication Critical patent/KR20130039672A/ko
Application granted granted Critical
Publication of KR101477123B1 publication Critical patent/KR101477123B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
KR1020120109748A 2011-10-12 2012-10-02 항체결합 펩타이드-페리틴 융합단백질 및 이의 용도 KR101477123B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110104339 2011-10-12
KR20110104339 2011-10-12

Publications (2)

Publication Number Publication Date
KR20130039672A KR20130039672A (ko) 2013-04-22
KR101477123B1 true KR101477123B1 (ko) 2014-12-29

Family

ID=48082633

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120109748A KR101477123B1 (ko) 2011-10-12 2012-10-02 항체결합 펩타이드-페리틴 융합단백질 및 이의 용도

Country Status (2)

Country Link
KR (1) KR101477123B1 (fr)
WO (1) WO2013055058A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017039383A1 (fr) * 2015-09-02 2017-03-09 경북대학교 산학협력단 Polypeptide de fusion constitué d'un polypeptide anti-inflammatoire et d'un fragment de monomère de ferritine liés par fusion et composition pharmaceutique destinée à prévenir et à traiter les maladies inflammatoires le contenant à titre de principe actif
WO2017039382A1 (fr) * 2015-09-02 2017-03-09 경북대학교 산학협력단 Fragment de monomère de ferritine d'origine humaine et polypeptide de fusion l'utilisant
WO2018128412A1 (fr) * 2017-01-06 2018-07-12 경북대학교 산학협력단 Peptide de fusion comprenant un peptide de ciblage de thrombus, un fragment de ferritine et un peptide thrombolytique, et son utilisation
WO2022092974A1 (fr) * 2020-10-30 2022-05-05 (주)셀레메디 Protéine de type anticorps et son utilisation
KR20220058480A (ko) 2020-10-30 2022-05-09 (주)셀레메디 항체 유사 단백질 및 그 용도

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014182136A1 (fr) 2013-05-10 2014-11-13 고려대학교 산학협력단 Protéine recombinée s'autoassemblant comprenant un peptide orienté vers une cible et son utilisation
KR101629362B1 (ko) * 2014-05-15 2016-06-10 한국생명공학연구원 루신 지퍼 쌍을 이용한 암 진단 및 치료용 조성물
KR20160094550A (ko) * 2015-01-30 2016-08-10 동국대학교 산학협력단 단일사슬항체조각과 페리틴을 포함하는 융합단백질 및 그의 용도
KR101712852B1 (ko) * 2016-05-18 2017-03-07 한국생명공학연구원 루신 지퍼 쌍을 이용한 암 진단 및 치료용 조성물
CN109803642B (zh) * 2016-07-15 2022-10-14 韩国科学技术研究院 新型纳米笼及其用途
KR102032647B1 (ko) 2018-04-03 2019-10-15 한양대학교 에리카산학협력단 미생물 검출용 구조체, 그의 제조 방법, 및 그 미생물 검출용 구조체를 이용한 미생물 검출 방법
US20220196655A1 (en) * 2019-04-25 2022-06-23 The Regents Of The University Of California Self-assembling protein nanocage decorated with antibodies (sapna) and parts thereof
KR102649246B1 (ko) * 2021-06-28 2024-03-20 한국과학기술연구원 Pd-1 부착 나노케이지 및 이의 용도
WO2023135187A1 (fr) * 2022-01-12 2023-07-20 Navigo Proteins Gmbh Purification de ferritine à haute affinité
WO2024157278A1 (fr) * 2023-01-27 2024-08-02 Invitrogen Bioservices India Private Limited Expression et criblage rapides de peptides pénétrants

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7097841B2 (en) * 2002-05-10 2006-08-29 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
US20090035389A1 (en) * 2007-02-23 2009-02-05 Specigen Inc. Targeted protein cages
KR20100001091A (ko) * 2008-06-26 2010-01-06 한국생명공학연구원 항체를 세포내로 도입하는 융합 펩타이드，및 이를 이용한세포이미징 및 약물전달

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100953917B1 (ko) * 2009-04-30 2010-04-22 고려대학교 산학협력단 항체의 Ｆｃ 영역에 특이적 결합능을 가지는 리포펩타이드 및 그를 포함하는 항원 인지형 지질 나노입자

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7097841B2 (en) * 2002-05-10 2006-08-29 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
US20090035389A1 (en) * 2007-02-23 2009-02-05 Specigen Inc. Targeted protein cages
KR20100001091A (ko) * 2008-06-26 2010-01-06 한국생명공학연구원 항체를 세포내로 도입하는 융합 펩타이드，및 이를 이용한세포이미징 및 약물전달

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Biotechnology and Bioengineering, Vol. 102, No. 4, pp. 1012-1024 (2009) *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017039383A1 (fr) * 2015-09-02 2017-03-09 경북대학교 산학협력단 Polypeptide de fusion constitué d'un polypeptide anti-inflammatoire et d'un fragment de monomère de ferritine liés par fusion et composition pharmaceutique destinée à prévenir et à traiter les maladies inflammatoires le contenant à titre de principe actif
WO2017039382A1 (fr) * 2015-09-02 2017-03-09 경북대학교 산학협력단 Fragment de monomère de ferritine d'origine humaine et polypeptide de fusion l'utilisant
US10513545B2 (en) 2015-09-02 2019-12-24 Kyungpook National University Industry-Academic Cooperation Foundation Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient
US10781238B2 (en) 2015-09-02 2020-09-22 Kyungpook National University Industry-Academic Cooperation Foundation Human-derived ferritin monomer fragment and fusion polypeptide using same
WO2018128412A1 (fr) * 2017-01-06 2018-07-12 경북대학교 산학협력단 Peptide de fusion comprenant un peptide de ciblage de thrombus, un fragment de ferritine et un peptide thrombolytique, et son utilisation
US11261236B2 (en) 2017-01-06 2022-03-01 Kyungpook National University Industry-Academic Cooperation Foundation Fusion peptide comprising thrombus-targeting peptide, ferritin fragment and thrombolytic peptide, and use thereof
WO2022092974A1 (fr) * 2020-10-30 2022-05-05 (주)셀레메디 Protéine de type anticorps et son utilisation
KR20220058480A (ko) 2020-10-30 2022-05-09 (주)셀레메디 항체 유사 단백질 및 그 용도
KR102561958B1 (ko) 2020-10-30 2023-08-01 (주)셀레메디 항체 유사 단백질 및 그 용도
KR20230117546A (ko) 2020-10-30 2023-08-08 (주)셀레메디 항체 유사 단백질 및 그 용도

Also Published As

Publication number Publication date
WO2013055058A3 (fr) 2013-08-01
WO2013055058A2 (fr) 2013-04-18
WO2013055058A9 (fr) 2013-06-13
KR20130039672A (ko) 2013-04-22

Similar Documents

Publication Publication Date Title
KR101477123B1 (ko) 항체결합 펩타이드-페리틴 융합단백질 및 이의 용도
JP7165366B2 (ja) ＩｇＧ結合ペプチドによる部位特異的ＲＩ標識抗体
CN102770764B (zh) 对给定靶标具有亲和力的人脂质运载蛋白2（Lcn2，hNGAL）的突变蛋白
Hui et al. Facile Method for the Site‐Specific, Covalent Attachment of Full‐Length IgG onto Nanoparticles
EP0713395A1 (fr) Vehicules polymeres pour la conjugaison non covalente de medicaments
JP5677453B2 (ja) Ｂｐｂベースのカーゴ運搬システム
KR20160094550A (ko) 단일사슬항체조각과 페리틴을 포함하는 융합단백질 및 그의 용도
US11377475B2 (en) Metal nanocluster scaffolds
Ghisaidoobe et al. Functionalized protein nanocages as a platform of targeted therapy and immunodetection
US8993715B2 (en) Labeled protein and method for obtaining the same
Niide et al. Enzymatic fabrication of protein-decorated gold nanoparticles by the aid of artificial peptides with gold-binding affinity
Castro-Hinojosa et al. A Simple and Versatile Strategy for Oriented Immobilization of His-Tagged Proteins on Magnetic Nanoparticles
JP5403681B2 (ja) 新規核内移行ペプチド
KR20180050261A (ko) 단일사슬항체조각과 바이러스 외피 단백질을 포함하는 융합단백질 및 이의 용도
KR101457186B1 (ko) 신규한 단백질 및 이의 용도
Kang et al. IgG Fc-binding peptide (FcBP)-tat conjugate as a smart antibody carrier into live cells
CN108341853B (zh) 人血清白蛋白特异性识别多肽及其应用
Li et al. The application of peptide functionalized gold nanoparticles
CN116217664A (zh) 靶向mHSP90的多肽、分子探针及应用
Glasgow Encapsulation of biomolecules in bacteriophage MS2 viral capsids
Aljabali CPMV as synthon and template in bionanotechnology

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20170927

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20181001

Year of fee payment: 5